查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541801

2024-2032 年适体市场报告（按类型（核酸、胜肽）、应用（诊断、治疗、研究和开发等）和地区）

Aptamers Market Report by Type (Nucleic Acid, Peptide), Application (Diagnostics, Therapeutics, Research and Developments, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球适配体市场规模达26亿美元。

适体是多功能寡核苷酸，可与特定标靶结合，包括蛋白质、胜肽、碳水化合物、小分子、毒素和活细胞。与抗体相比，它们具有可修饰性、非免疫原性、敏感性高、毒性低、易于製备、分子量低且不同製剂不存在差异等特点。因此，它们被广泛用于治疗和生物技术应用。除此之外，它们还被用作研究剂、诊断剂、生物感测器以及全球生物标记或药物发现的工具。

全球适体市场趋势：

癌症、神经退化性疾病、心血管疾病和后天免疫缺乏症候群（爱滋病）等危及生命的疾病的日益流行，是影响基于适体疗法的新型有效检测方法需求的关键因素之一。此外，增加核酸酶抗性并增强适体治疗特性的化学修饰製程的出现正在推动市场成长。适配体市场的成长也可以归因于为改善诊断设备和药物及其载体而进行的研发（R&D）活动数量的增加。除此之外，由于适配体是化学合成的，消除了批次之间的差异并且需要更少的开发时间，因此它们的应用在全球范围内广泛增加。此外，私人组织正在与学术机构和研究实验室合作，推出下一代产品并扩大其现有的市场份额。预计这将推动适体在广泛的医学治疗以及食品和饮料 (F&B) 行业中的使用。

本报告回答的关键问题：

  • 迄今为止，全球适配体市场表现如何，未来几年将如何表现？
  • COVID-19对全球适配体市场有何影响？
  • 主要区域市场有哪些？
  • 依类型划分市场是怎么样的？
  • 基于应用程式的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球适配体市场结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球适体市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 核酸
    • 市场趋势
    • 市场预测
  • 胜肽
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 诊断
    • 市场趋势
    • 市场预测
  • 疗法
    • 市场趋势
    • 市场预测
  • 研究与开发
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aptagen LLC
    • Aptamer Group
    • Aptamer Sciences Inc.
    • Aptus Biotech SL
    • Base Pair Biotechnologies Inc.
    • IBA GmbH
    • Kaneka Eurogentec SA (Kaneka Corporation)
    • NeoVentures Biotechnology Inc.
    • NOXXON Pharma
    • SomaLogic Inc.
    • TriLink BioTechnologies LLC
    • Vivonics Inc.
Product Code: SR112024A3845

The global aptamers market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 17.8% during 2024-2032.

Aptamers are versatile oligonucleotides that bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and live cells. They are modifiable, nonimmunogenic, highly sensitive, less toxic, easy to prepare and have low molecular weight and no variation with different preparations as compared to antibodies. As a result, they are widely being used in therapeutic and biotechnological applications. Besides this, they are also utilized as research agents, diagnostics, biosensors, and tools for biomarker or drug discovery worldwide.

Global Aptamers Market Trends:

The growing prevalence of life-threatening diseases, such as cancer, neurodegenerative, cardiovascular, and acquired immunodeficiency syndrome (AIDS), represents one of the key factors influencing the demand for new and effective detection assays based on aptamer therapy. Moreover, the advent of the chemical modification process to increase the nuclease resistance and enhance the therapeutic properties of aptamers is bolstering the market growth. The aptamers market growth can also be accredited to the rising number of research and development (R&D) activities undertaken for improving diagnostic devices and drugs and their carriers. Apart from this, as aptamers are chemically synthesized, which eliminates batch-to-batch variation and requires less time for development, their application is extensively increasing across the globe. Furthermore, private organizations are collaborating with academic institutes and research laboratories to introduce next-generation products and expand their existing market presence. This is anticipated to fuel the usage of aptamers in a wide range of medical therapies, as well as in the food and beverage (F&B) industry.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global aptamers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type and application.

Breakup by Type:

Nucleic Acid

Peptide

Breakup by Application:

Diagnostics

Therapeutics

Research and Developments

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aptagen LLC, Aptamer Group, Aptamer Sciences Inc., Aptus Biotech S.L., Base Pair Biotechnologies Inc., IBA GmbH, Kaneka Eurogentec S.A. (Kaneka Corporation), NeoVentures Biotechnology Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies LLC and Vivonics Inc.

Key Questions Answered in This Report:

  • How has the global aptamers market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global aptamers market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global aptamers market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Aptamers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Nucleic Acid
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Peptide
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Therapeutics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Research and Developments
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Aptagen LLC
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Aptamer Group
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Aptamer Sciences Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Aptus Biotech S.L.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Base Pair Biotechnologies Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 IBA GmbH
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Kaneka Eurogentec S.A. (Kaneka Corporation)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 NeoVentures Biotechnology Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 NOXXON Pharma
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 SomaLogic Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 TriLink BioTechnologies LLC
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Vivonics Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Aptamers Market: Major Drivers and Challenges
  • Figure 2: Global: Aptamers Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Aptamers Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Aptamers Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Aptamers Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Aptamers Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Aptamers (Nucleic Acid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Aptamers (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Aptamers (Peptide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Aptamers (Peptide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Aptamers (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Aptamers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Aptamers (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Aptamers (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Aptamers (Research and Developments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Aptamers (Research and Developments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Aptamers (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Aptamers (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: North America: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: North America: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: United States: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: United States: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Canada: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Canada: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Asia-Pacific: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Asia-Pacific: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: China: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: China: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Japan: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Japan: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: India: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: India: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: South Korea: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: South Korea: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Australia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Australia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Indonesia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Indonesia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Germany: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Germany: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: France: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: France: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United Kingdom: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United Kingdom: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Italy: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Italy: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Spain: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Spain: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Russia: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Russia: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Latin America: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Latin America: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Brazil: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Brazil: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Mexico: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Mexico: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Middle East and Africa: Aptamers Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Middle East and Africa: Aptamers Market: Breakup by Country (in %), 2023
  • Figure 67: Middle East and Africa: Aptamers Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Global: Aptamers Industry: SWOT Analysis
  • Figure 69: Global: Aptamers Industry: Value Chain Analysis
  • Figure 70: Global: Aptamers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Aptamers Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Aptamers Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Aptamers Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Aptamers Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Aptamers Market: Competitive Structure
  • Table 6: Global: Aptamers Market: Key Players